CannaPharmaRx, Inc. (CPMD) stock
Close on Oct 16, 2026Market cap $1.36MP/E –Yield –
CannaPharmaRx, Inc. grew revenue 24.8% to $1.70M over the twelve months to Jun 30, 2026. Free cash flow was -$794.62K. At the latest close the market valued the company at $1.36M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.36M
- P/E ratio
- –
- Price to sales
- 0.80
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -58.22%
Fundamentals
- Revenue
- $1.70M
- Net income
- -$11.32M
- EPS, diluted
- -$0.02
- Free cash flow
- -$794.62K
- Book value per share
- -$0.05
- Diluted shares
- 682M
Trading
- Previous close
- $0.00
- Open
- $0.00
- Day's range
- $0.00 – $0.00
- Volume
- 0
- Average volume (20 days)
- 7,195
Market cap history
Month-end market cap since 2010, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 16, 2026. The S&P 500 is measured by the SPY fund.
| Period | CPMD | S&P 500 | Difference | CPMD per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | 0.0% | +1.5% | −1.5 pts | ||
| 3 months | -13.0% | +1.9% | −15.0 pts | ||
| Year to date | -61.5% | +12.8% | −74.3 pts | ||
| 1 year | -58.3% | +16.8% | −75.1 pts | ||
| 3 years | -75.0% | +81.5% | −156.5 pts | -37.0% | +22.0% |
| 5 years | -94.3% | +83.0% | −177.3 pts | -43.6% | +12.8% |
| 10 years | -99.7% | +319.4% | −419.0 pts | -43.7% | +15.4% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases CannaPharmaRx filed with the SEC as exhibits to Form 8-K or 6-K
About CannaPharmaRx
Pharmaceutical Preparations
CannaPharmaRx, Inc. acquires, develops, and operates indoor cannabis cultivation facilities to produce medical cannabis and craft products. The company primarily produces and distributes dried cannabis flower, packaged and marketed as dried flower and trim shake across premium and medium quality batches. Its operations encompass standard cultivation, processing, and distribution of cannabis through its operating subsidiary. Target markets for its cannabis products include consumers and wholesale channels in Canada, Germany, Israel, and Portugal.
Company profile, executives and historyCannaPharmaRx stock: common questions
What is CannaPharmaRx's stock price?
CPMD closed at $0.00 on Oct 16, 2026, up 0.00% on the day.
What is CannaPharmaRx's market cap?
CannaPharmaRx was worth $1.36M at the close on Oct 16, 2026: the share price times the diluted shares outstanding.
What is CPMD's P/E ratio?
CannaPharmaRx lost money over fiscal 2025 (diluted EPS -$0.02), so it has no meaningful P/E ratio.
How much revenue does CannaPharmaRx make?
CannaPharmaRx reported revenue of $1.70M for the twelve months to Jun 30, 2026, up 24.8% from a year earlier.
Does CannaPharmaRx pay a dividend?
No. CannaPharmaRx has not paid a cash dividend over the last twelve months.
How has CPMD stock performed over the past year?
Including dividends, CPMD returned -58.3% over the past year, against +16.8% for the S&P 500.
Who are CannaPharmaRx's competitors?
Companies most similar to CannaPharmaRx by business, industry and size include CBDY, SXTC, MTRI, SPRC, PMHS.
See a number that looks wrong?